Genus Share Price Rally Cotninues: Forges Chinese Porcine Joint Venture, Eyes $160M Windfall

Genus (LSE: GNS), a global leader in animal genetics, has seen its share price edge up on Monday, climbing around 0.3% and adding to its strong recent run. The stock is up 21.7% year-to-date.

The company announced it has successfully formed its Chinese porcine joint venture as of January 31, 2026, setting the stage for accelerated growth in the critical Chinese market. This strategic move, initially announced on September 4, 2025, sees Genus partnering with Beijing Capital Agribusiness to bolster its PIC China operations.

The formation of the joint venture triggers a substantial influx of capital for Genus. The company anticipates receiving a gross cash payment of US$160 million. After accounting for withholding taxes and transaction costs, the net proceeds are estimated at US$140 million, subject to standard working capital and net debt adjustments. This is in addition to a previously recognized gross milestone payment of US$7.5 million during the first half of the fiscal year.

With Genus holding a 49% ownership stake in the joint venture, PIC China will be deconsolidated from the group's financial statements. Management plans to delve into the pro-forma implications of this structural change during the upcoming interim results announcement scheduled for February 26, 2026.

This strategic partnership is poised to unlock significant opportunities within the Chinese market, leveraging Beijing Capital Agribusiness's local expertise and infrastructure. Genus anticipates that the joint venture will accelerate the adoption of its advanced porcine genetics, enhancing productivity and efficiency for Chinese pork producers.